Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dwayne Campbell

Clinical Cardiac Electrophysiology West Des Moines, IA Medical Doctor

NPI 1861601841 CMS profile 129569

5880 University Ave Ste 112, West Des Moines, IA 50266

Open in the dashboard

General payments

$36,903

496 records reported · program years 2019–2025

Research payments

$21

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$393,311 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Dwayne Campbell of West Des Moines, IA is reported in the CMS Open Payments database as having received $36,903 across 496 general payments and $21 in research payments paid to them. Separately, studies naming them as principal investigator received $393,311 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 68th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,047 69
2024 General $13,314 104
2023 General $3,589 74
2023 Research $21 1
2022 General $5,502 102
2021 General $4,994 30
2020 General $3,792 58
2019 General $3,667 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dwayne Campbell
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Dwayne Campbell were reported at $2,047. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Dwayne Campbell Clinical Cardiac Electrophysiology median Middle half National median
2019 $3,667 $2,361 $585–$8,260 $163
2020 $3,792 $993 $247–$4,351 $114
2021 $4,994 $1,185 $326–$4,739 $132
2022 $5,502 $2,073 $554–$6,789 $149
2023 $3,589 $2,568 $759–$8,159 $160
2024 $13,314 $2,557 $703–$7,403 $164
2025 $2,047 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $19,377 80 payments
  2. Medtronic Vascular, Inc. $5,669 71 payments
  3. Abbott Laboratories $5,463 175 payments
  4. Boston Scientific Corporation $2,120 85 payments
  5. Philips Electronics North America Corporation $1,483 18 payments
  6. Atricure, Inc. $862 11 payments
  7. Biosense Webster, Inc. $270 3 payments
  8. Impulse Dynamics (USA) Inc. $224 3 payments
  9. Cardiva Medical, Inc. $205 7 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $186 11 payments
  11. Other $1,045 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $14,257 446 payments
  2. Travel and Lodging $12,006 43 payments
  3. Consulting Fee $6,300 4 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,100 1 payment
  5. Education $240 2 payments
Products named General payments · program years 2019–2025
  1. AURORA EV-ICD MRI SURESCAN $2,896 24 payments
  2. Performa $1,702 8 payments
  3. PULSESELECT $1,439 6 payments
  4. AVEIR $1,202 7 payments
  5. AGILIS $923 7 payments
  6. MICRA Pacemakers $838 25 payments
  7. (9520) IGT Devices Und $716 4 payments
  8. WATCHMAN Access System $591 63 payments
  9. Micra Pacemakers $551 12 payments
  10. ENSITE PRECISION $531 37 payments
  11. Other $9,500 268 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $21 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 20 drugs

Part D claims

1,586

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$354,841

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

44.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 374 $283,392
Xarelto Rivaroxaban Brand 54 $50,605
Dofetilide Generic 20 $8,239
Amiodarone Hcl Generic 215 $2,116
Flecainide Acetate Generic 57 $1,987
Sotalol Sotalol Hcl Brand 79 $1,973
Metoprolol Succinate Generic 181 $1,562
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 38 $945
Clopidogrel Clopidogrel Bisulfate Brand 145 $820
Mexiletine Hcl Generic 11 $688

The 10 drugs with the highest cost, of 20 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$180,748

Medicare's payments for the services billed

Medicare patients

1,024

Average age 77

Services billed

2,409

434 women, 590 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 73%
Heart failure 53%
Ischemic heart disease 51%
Arthritis 43%
Chronic kidney disease 40%
Diabetes 35%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $21
$21 374 —
LEQVIO
  • Novartis Pharmaceuticals Corporation $21
$21 — —
ENTRESTO
  • Novartis Pharmaceuticals Corporation $21
$21 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $16
$16 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

497 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record